JB Pritzker Claims GLP-1 Aided in His 80-Pound Weight Loss

JB Pritzker Claims GLP-1 Aided in His 80-Pound Weight Loss

Illinois Governor’s Weight Loss and Coverage for GLP-1 Drugs Governor JB Pritzker of Illinois announced on Monday that GLP-1 weight-loss medications are covered for 55,000 state employees. In the same interview, he shared that he has personally lost 80 pounds while using the medication. The Democrat made this announcement during an interview with CBS News, […]

‘It’s always challenging to remove a benefit’: CEO of a major Massachusetts health insurer talks about the decision to limit GLP-1 weight-loss medications.

‘It's always challenging to remove a benefit’: CEO of a major Massachusetts health insurer talks about the decision to limit GLP-1 weight-loss medications.

Interview with Patrick Gilligan: Reflections and Future Insights In a recent conversation, Patrick Gilligan discussed his initial year at Point32Health and shared his expectations for the rest of 2026. This interview has been shortened for clarity. Q: What do you believe is central to the current challenges facing the health system? Answer: Well, it’s been […]

Use of GLP-1 medications in the U.S. almost increases fourfold in just two years

Use of GLP-1 medications in the U.S. almost increases fourfold in just two years

America is Losing Weight One Shot at a Time The number of U.S. adults using popular GLP-1 medications like Ozempic and Wigovy for weight loss has surged, increasing nearly fourfold in just two years. This uptick is evident on a larger scale, as obesity rates across the country show a slow but steady decline after […]

GLP-1 agonists associated with quicker advancement of certain neurological disorders

GLP-1 agonists associated with quicker advancement of certain neurological disorders

Neurologists Issue Caution on GLP-1 Drugs and Neurodegenerative Diseases Neurologists are raising alarms about the possible adverse effects that popular weight loss medications may have on neurodegenerative diseases like ALS. Dr. Jincy Andrews, a neurologist and director at the NYU Langone ALS Center, points out that while these drugs promote quick weight loss—something that attracts […]